NEW YORK (360Dx) – Accelerate Diagnostics said on Sunday that it anticipates its fourth quarter revenues to be down 14 percent year over year.

Accelerate's total fourth quarter revenues are expected to retreat to approximately $1.8 million from $2.1 million a year ago. The figure would miss the analysts' average estimate of $2.7 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.